Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Sagimet Biosciences Inc.: Filed eleventh amended and restated certificate of incorporation effective upon closing of IPO, reclassifying common stock, authorizing new classes of common and preferred stock, and eliminating references to previous preferred series (effective 2023-07-18).
- Change
- charter amendment
- Effective
- 2023-07-18
Exact text from the filing
on July 18, 2023 and in connection with the closing of the initial public offering of the Company’s Series A common stock (the “IPO”), the Company filed an eleventh amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Sagimet Biosciences Inc.: Second amended and restated bylaws became effective upon closing of IPO, eliminating stockholder action by written consent, establishing stockholder proposal and director nomination procedures, and conforming to amended charter (effective 2023-07-18).
- Change
- bylaw amendment
- Effective
- 2023-07-18
Exact text from the filing
on July 18, 2023 in connection with the closing of the IPO, the second amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), previously approved by the Board and the Company’s stockholders to become effective upon the closing of the IPO, became effective.
View on SEC.gov